Results 111 to 120 of about 2,984 (199)

Refractory/Resistant Cytomegalovirus Infection in Transplant Recipients: An Update

Viruses
Despite the significant progress made, CMV infection is one of the most frequent infectious complications in transplant recipients. CMV infections that become refractory or resistant (R/R) to the available antiviral drugs constitute a clinical challenge ...
Léna Royston, Genovefa A. Papanicolaou, Dionysios Neofytos   +2 more
doaj   +1 more source

Computational Investigation of Novel pUL56 Ligands Using Docking and Molecular Dynamics with Preliminary Cytotoxicity Evaluation: An Early-Stage Study

Molecules
Human cytomegalovirus (HCMV) remains a significant cause of morbidity in immunocompromised patients, necessitating the development of improved antivirals.
Viktoria Feoktistova, Samson Olusegun Afolabi, Artem M. Klabukov, Anna A. Shtro, Aleksei V. Kolobov, Ruslan I. Baichurin, Ekaterina V. Skorb, Sergey Shityakov   +7 more
doaj   +1 more source

Exploring neural models for human cytomegalovirus infection studies [PDF]

This thesis explores the use of clinical CMV isolates in the validation of antiviral effects against CMV infection of human CNS models in the context of cCMV disease. Next, it elucidates the use of advanced human neuronal models in CMV research.
Mulder, L.A.
core   +2 more sources

Beyond valganciclovir: A meta-analysis of letermovir's safety and efficacy in cytomegalovirus prophylaxis after solid organ transplantation. [PDF]

BMC Infect Dis
Usman M, Yuan Z, Yu H, Chen X, Tang Z, Liu C, Li Z, He W, Xu K.   +8 more
europepmc   +1 more source

An Analysis of Cytomegalovirus-Specific Cell-Mediated Immunity in a Phase 3, Randomized, Placebo-Controlled Trial of Letermovir Prophylaxis in Cytomegalovirus-Seropositive Recipients of an Allogeneic Hematopoietic Cell Transplant. [PDF]

Clin Infect Dis
Papanicolaou GA, Dadwal SS, Ariza-Heredia EJ, Chiusolo P, Morris MI, Tholouli E, Haber B, Broyde N, Gilbert CL, Badshah C.   +9 more
europepmc   +1 more source

Screening and characterization of novel chemical compounds inhibiting cytomegalovirus infection [PDF]

, 2019
Nahrevanian, Shahab
core   +1 more source

Treatment of CMV infection after allogeneic hematopoietic stem cell transplantation [PDF]

, 2016
Brunello, Lucia, Bruno, Benedetto, Busca, Alessandro, Festuccia, Moreno Benedetto, Giaccone, Luisa, Maffini, Enrico   +5 more
core   +1 more source

Letermovir Prophylaxis for Cytomegalovirus Infection in Adult Allogeneic Stem Cell Transplantation: A Retrospective Analysis From a Lower-Middle-Income Country. [PDF]

Cureus
Rastogi N, Bhayana S, Chahal K, Kumar NM, Swaminathan A, Panda A, Bharat S, Chizaram O, Nathany S, Paul A, Agrawal R, Dua V, Bhargava R.   +12 more
europepmc   +1 more source

Cytomegalovirus (CMV)-Specific Cell-Mediated Immunity for Prediction of Postprophylaxis CMV Disease in a Phase 3 Trial of Letermovir Versus Valganciclovir Prophylaxis in Donor CMV-Seropositive/Recipient CMV-Seronegative Kidney Transplant Recipients. [PDF]

Clin Infect Dis
Limaye AP, Crespo M, Kamar N, Humar A, Carroll RP, Pereira MR, Broyde N, Wang W, Haber B.   +8 more
europepmc   +1 more source

An update on the treatment of cytomegalovirus infection after allogeneic hematopoietic stem cell transplantation [PDF]

, 2019
Bruno, B., Busca, A., Cavallo, R., Cerrano, M., Costa, C., Curtoni, A., Giaccone, L., Maffini, E.   +7 more
core   +1 more source